In vitro results with minimal blood toxicity of a combretastatin A4 analogue.
Chagas C, Mansano JV, da Silva EB, Petri G, da Costa Aguiar Alves Reis B, Schumacher ML, Haddad PS, Pereira EC, Britos TN, Barreiro EJ, Lima LM, Ferreira FF, Fonseca FLA.
Chagas C, et al. Among authors: lima lm.
Invest New Drugs. 2024 May 17. doi: 10.1007/s10637-024-01440-4. Online ahead of print.
Invest New Drugs. 2024.
PMID: 38758478